Detection of gyrA and gyrB mutations in Clostridium difficile isolates by real-time PCR
- 30 April 2010
- journal article
- Published by Elsevier in Molecular and Cellular Probes
- Vol. 24 (2) , 61-67
- https://doi.org/10.1016/j.mcp.2009.10.002
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Molecular Analysis of the gyrA and gyrB Quinolone Resistance-Determining Regions of Fluoroquinolone-Resistant Clostridium difficile Mutants Selected In VitroAntimicrobial Agents and Chemotherapy, 2009
- Fluoroquinolone resistance in Clostridium difficile isolates from a prospective study of C. difficile infections in EuropeJournal of Medical Microbiology, 2008
- Moxifloxacin Therapy as a Risk Factor forClostridium difficile–Associated Disease During an Outbreak: Attempts to Control a New Epidemic StrainInfection Control & Hospital Epidemiology, 2007
- Narrative Review: The New Epidemic of Clostridium difficile–Associated Enteric DiseaseAnnals of Internal Medicine, 2006
- Emergence of Clostridium difficile-associated disease in North America and EuropeClinical Microbiology & Infection, 2006
- Emergence of Fluoroquinolones as the Predominant Risk Factor for Clostridium difficile-Associated Diarrhea: A Cohort Study during an Epidemic in QuebecClinical Infectious Diseases, 2005
- A Large Outbreak ofClostridium difficile–Associated Disease with an Unexpected Proportion of Deaths and Colectomies at a Teaching Hospital Following Increased Fluoroquinolone UseInfection Control & Hospital Epidemiology, 2005
- gyrA and gyrB Mutations Are Implicated in Cross-Resistance to Ciprofloxacin and Moxifloxacin in Clostridium difficileAntimicrobial Agents and Chemotherapy, 2002
- Clostridium difficile ColitisNew England Journal of Medicine, 1994
- Nosocomial Acquisition ofClostridium difficileInfectionNew England Journal of Medicine, 1989